Steven N. Wolff
Aastrom Biosciences (United States) · 43 works · 3,873 citations · h-index 26
Top works
- Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
- Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.
- Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma.
- High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot study
- Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia
- Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation
- Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients.
- Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.
- High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study.
- The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation
- High-dose VP-16-213 monotherapy for refractory germinal malignancies: a phase II study.
- High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer.
- In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy
- Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma.
- Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation
- Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia
- Etoposide kinetics in patients with obstructive jaundice.
- High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lung.
- High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group
- T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients.